Waters Corporation (WAT) EV/EBITDA Ratio: 37.11x
Is Waters Corporation’s EV/EBITDA ratio high or low?
Waters Corporation's EV/EBITDA ratio of 37.11x is 73% above its 5-year average of 21.47x, near the high end of its 5-year range (15.91x–39.61x).
As of Sunday, June 14, 2026. 70.82% above its 12-month average of 21.72x.
WAT EV/EBITDA Ratio Chart
WAT Average EV/EBITDA Ratio Chart
WAT Current vs Average EV/EBITDA Ratio Chart
WAT EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
37.11x
EV/EBITDA RATIO AVG TTM
21.72x
EV/EBITDA RATIO AVG 3Y
21.28x
EV/EBITDA RATIO AVG 5Y
21.47x
EV/EBITDA RATIO AVG 10Y
20.79x
EV/EBITDA RATIO AVG 15Y
19.25x
EV/EBITDA RATIO AVG 20Y
18.18x
CURRENT VS TTM AVG
+70.82%
CURRENT VS 3Y AVG
+74.38%
CURRENT VS 5Y AVG
+72.81%
CURRENT VS 10Y AVG
+78.53%
CURRENT VS 15Y AVG
+92.81%
CURRENT VS 20Y AVG
+104.08%
WAT Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.17B | 37.11x | 21.72x | 21.28x | 21.47x |
| United Therapeutics Corporation (UTHR) | $23.17B | 14.41x | 11.89x | 10.20x | 11.38x |
| BioNTech SE (BNTX) | $22.90B | N/A | 51.40x | 19.63x | 20.05x |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 20.60x | 23.58x | 23.88x | 26.49x |
| Labcorp Holdings Inc. (LH) | $21.83B | 13.73x | 14.69x | 14.58x | 11.71x |
| Veeva Systems Inc. (VEEV) | $25.92B | 19.17x | 33.23x | 43.96x | 53.99x |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 12.39x | 25.28x | 25.28x |
| DexCom, Inc. (DXCM) | $29.08B | 20.28x | 25.32x | 42.50x | 70.63x |
| Hologic, Inc. (HOLX) | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
| Biogen Inc. (BIIB) | $29.53B | 12.16x | 8.71x | 11.20x | 12.24x |
EV/EBITDA vs. its own history
At 37.1, EV/EBITDA is richer than usual, sitting higher than 100% of its 20-year history.
20-year low
6.8
median
18.1
20-year high
39.6
Waters Corporation EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Waters Corporation (WAT)?
- The EV/EBITDA ratio for WAT stock is 37.11x.
- Is Waters Corporation's EV/EBITDA ratio high or low?
- Waters Corporation's EV/EBITDA ratio of 37.11x is 73% above its 5-year average of 21.47x, near the high end of its 5-year range (15.91x–39.61x).
- What is the TTM average EV/EBITDA ratio for Waters Corporation (WAT)?
- The TTM average EV/EBITDA ratio for WAT stock is 21.72x.
- What is the 3Y average EV/EBITDA ratio for Waters Corporation (WAT)?
- The 3Y average EV/EBITDA ratio for WAT stock is 21.28x.
- What is the 5Y average EV/EBITDA ratio for Waters Corporation (WAT)?
- The 5Y average EV/EBITDA ratio for WAT stock is 21.47x.
- What is the 10Y average EV/EBITDA ratio for Waters Corporation (WAT)?
- The 10Y average EV/EBITDA ratio for WAT stock is 20.79x.
- What is the 15Y average EV/EBITDA ratio for Waters Corporation (WAT)?
- The 15Y average EV/EBITDA ratio for WAT stock is 19.25x.
- What is the 20Y average EV/EBITDA ratio for Waters Corporation (WAT)?
- The 20Y average EV/EBITDA ratio for WAT stock is 18.18x.
Waters Corporation EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-12 | 37.11x |
| 2026-06-11 | 37.49x |
| 2026-06-10 | 37.79x |
| 2026-06-09 | 38.50x |
| 2026-06-08 | 37.81x |
| 2026-06-05 | 37.99x |
| 2026-06-04 | 38.97x |
| 2026-06-03 | 39.27x |
| 2026-06-02 | 38.57x |
| 2026-06-01 | 39.12x |
| 2026-05-29 | 39.61x |
| 2026-05-28 | 38.10x |
| 2026-05-27 | 35.93x |
| 2026-05-26 | 35.61x |
| 2026-05-22 | 35.94x |
| 2026-05-21 | 35.82x |
| 2026-05-20 | 35.85x |
| 2026-05-19 | 35.14x |
| 2026-05-18 | 35.04x |
| 2026-05-15 | 34.78x |
| 2026-05-14 | 35.13x |
| 2026-05-13 | 35.28x |
| 2026-05-12 | 36.82x |
| 2026-05-11 | 21.18x |
| 2026-05-08 | 21.59x |
| 2026-05-07 | 21.32x |
| 2026-05-06 | 21.26x |
| 2026-05-05 | 20.85x |
| 2026-05-04 | 18.48x |
| 2026-05-01 | 18.79x |
| 2026-04-30 | 18.91x |
| 2026-04-29 | 17.91x |
| 2026-04-28 | 18.42x |
| 2026-04-27 | 18.36x |
| 2026-04-24 | 18.95x |
| 2026-04-23 | 19.03x |
| 2026-04-22 | 20.38x |
| 2026-04-21 | 20.43x |
| 2026-04-20 | 20.45x |
| 2026-04-17 | 19.99x |
| 2026-04-16 | 19.48x |
| 2026-04-15 | 19.90x |
| 2026-04-14 | 20.18x |
| 2026-04-13 | 19.81x |
| 2026-04-10 | 19.54x |
| 2026-04-09 | 19.40x |
| 2026-04-08 | 19.45x |
| 2026-04-07 | 18.80x |
| 2026-04-06 | 18.61x |
| 2026-04-02 | 18.62x |
| 2026-04-01 | 18.37x |
| 2026-03-31 | 18.24x |
| 2026-03-30 | 17.99x |
| 2026-03-27 | 17.74x |
| 2026-03-26 | 18.41x |
| 2026-03-25 | 18.51x |
| 2026-03-24 | 18.48x |
| 2026-03-23 | 18.48x |
| 2026-03-20 | 18.31x |
| 2026-03-19 | 18.35x |
| 2026-03-18 | 18.08x |
| 2026-03-17 | 18.20x |
| 2026-03-16 | 17.79x |
| 2026-03-13 | 17.59x |
| 2026-03-12 | 17.40x |
| 2026-03-11 | 18.23x |
| 2026-03-10 | 18.35x |
| 2026-03-09 | 18.70x |
| 2026-03-06 | 18.52x |
| 2026-03-05 | 19.28x |
| 2026-03-04 | 19.48x |
| 2026-03-03 | 19.08x |
| 2026-03-02 | 18.79x |
| 2026-02-27 | 19.50x |
| 2026-02-26 | 19.70x |
| 2026-02-25 | 19.51x |
| 2026-02-24 | 19.91x |
| 2026-02-23 | 19.99x |
| 2026-02-20 | 20.02x |
| 2026-02-19 | 19.75x |
| 2026-02-18 | 19.68x |
| 2026-02-17 | 19.34x |
| 2026-02-13 | 19.45x |
| 2026-02-12 | 19.25x |
| 2026-02-11 | 19.78x |
| 2026-02-10 | 19.66x |
| 2026-02-09 | 19.72x |
| 2026-02-06 | 22.75x |
| 2026-02-05 | 22.50x |
| 2026-02-04 | 22.93x |
| 2026-02-03 | 22.62x |
| 2026-02-02 | 22.64x |
| 2026-01-30 | 22.15x |
| 2026-01-29 | 22.41x |
| 2026-01-28 | 22.97x |
| 2026-01-27 | 23.26x |
| 2026-01-26 | 23.30x |
| 2026-01-23 | 23.38x |
| 2026-01-22 | 23.85x |
| 2026-01-21 | 23.63x |
| 2026-01-20 | 22.90x |
| 2026-01-16 | 23.10x |
| 2026-01-15 | 23.51x |
| 2026-01-14 | 23.43x |
| 2026-01-13 | 23.48x |
| 2026-01-12 | 23.46x |
| 2026-01-09 | 23.64x |
| 2026-01-08 | 23.63x |
| 2026-01-07 | 23.79x |
| 2026-01-06 | 23.85x |
| 2026-01-05 | 23.54x |
| 2026-01-02 | 22.79x |
| 2025-12-31 | 22.67x |
| 2025-12-30 | 22.91x |
| 2025-12-29 | 22.97x |
| 2025-12-26 | 23.03x |
| 2025-12-24 | 22.96x |
| 2025-12-23 | 22.86x |
| 2025-12-22 | 22.92x |
| 2025-12-19 | 22.57x |
| 2025-12-18 | 22.47x |
| 2025-12-17 | 22.52x |
| 2025-12-16 | 22.60x |
| 2025-12-15 | 22.99x |
| 2025-12-12 | 22.99x |
| 2025-12-11 | 23.38x |
| 2025-12-10 | 23.58x |
| 2025-12-09 | 23.03x |
| 2025-12-08 | 23.41x |
| 2025-12-05 | 23.53x |
| 2025-12-04 | 23.62x |
| 2025-12-03 | 23.69x |
| 2025-12-02 | 23.74x |
| 2025-12-01 | 23.70x |
| 2025-11-28 | 24.02x |
| 2025-11-26 | 24.23x |
| 2025-11-25 | 24.54x |
| 2025-11-24 | 23.80x |
| 2025-11-21 | 23.48x |
| 2025-11-20 | 22.60x |
| 2025-11-19 | 22.47x |
| 2025-11-18 | 22.49x |
| 2025-11-17 | 22.57x |
| 2025-11-14 | 22.65x |
| 2025-11-13 | 22.64x |
| 2025-11-12 | 23.10x |
| 2025-11-11 | 23.03x |
| 2025-11-10 | 22.48x |
| 2025-11-07 | 22.21x |
| 2025-11-06 | 22.18x |
| 2025-11-05 | 22.22x |
| 2025-11-04 | 21.96x |
| 2025-11-03 | 20.61x |
| 2025-10-31 | 20.83x |
| 2025-10-30 | 20.45x |
| 2025-10-29 | 20.49x |
| 2025-10-28 | 20.63x |
| 2025-10-27 | 20.95x |
| 2025-10-24 | 21.39x |
| 2025-10-23 | 21.18x |
| 2025-10-22 | 20.78x |
| 2025-10-21 | 20.81x |
| 2025-10-20 | 20.47x |
| 2025-10-17 | 19.99x |
| 2025-10-16 | 20.00x |
| 2025-10-15 | 19.86x |
| 2025-10-14 | 19.90x |
| 2025-10-13 | 20.08x |
| 2025-10-10 | 19.78x |
| 2025-10-09 | 19.75x |
| 2025-10-08 | 19.59x |
| 2025-10-07 | 19.07x |
| 2025-10-06 | 19.59x |
| 2025-10-03 | 19.64x |
| 2025-10-02 | 19.27x |
| 2025-10-01 | 19.15x |
| 2025-09-30 | 18.02x |
| 2025-09-29 | 17.44x |
| 2025-09-26 | 17.57x |
| 2025-09-25 | 17.35x |
| 2025-09-24 | 17.62x |
| 2025-09-23 | 17.99x |
| 2025-09-22 | 18.17x |
| 2025-09-19 | 18.08x |
| 2025-09-18 | 18.39x |
| 2025-09-17 | 18.24x |
| 2025-09-16 | 18.21x |
| 2025-09-15 | 17.98x |
| 2025-09-12 | 17.77x |
| 2025-09-11 | 18.17x |
| 2025-09-10 | 17.64x |
| 2025-09-09 | 18.06x |
| 2025-09-08 | 18.56x |
| 2025-09-05 | 18.39x |
| 2025-09-04 | 18.02x |
| 2025-09-03 | 17.47x |
| 2025-09-02 | 17.84x |
| 2025-08-29 | 18.14x |
| 2025-08-28 | 17.90x |
| 2025-08-27 | 17.73x |
| 2025-08-26 | 17.82x |
| 2025-08-25 | 17.97x |
| 2025-08-22 | 18.16x |
| 2025-08-21 | 17.49x |
| 2025-08-20 | 17.85x |
| 2025-08-19 | 17.91x |
| 2025-08-18 | 17.44x |
| 2025-08-15 | 17.56x |
| 2025-08-14 | 17.67x |
| 2025-08-13 | 17.86x |
| 2025-08-12 | 17.22x |
| 2025-08-11 | 16.87x |
| 2025-08-08 | 16.97x |
| 2025-08-07 | 16.79x |
| 2025-08-06 | 16.78x |
| 2025-08-05 | 16.97x |
| 2025-08-04 | 17.22x |
| 2025-08-01 | 17.54x |
| 2025-07-31 | 17.45x |
| 2025-07-30 | 18.04x |
| 2025-07-29 | 18.27x |
| 2025-07-28 | 18.22x |
| 2025-07-25 | 18.26x |
| 2025-07-24 | 18.00x |
| 2025-07-23 | 17.84x |
| 2025-07-22 | 17.38x |
| 2025-07-21 | 17.05x |
| 2025-07-18 | 17.38x |
| 2025-07-17 | 17.92x |
| 2025-07-16 | 17.50x |
| 2025-07-15 | 17.50x |
| 2025-07-14 | 18.33x |
| 2025-07-11 | 21.09x |
| 2025-07-10 | 21.11x |
| 2025-07-09 | 20.88x |
| 2025-07-08 | 20.80x |
| 2025-07-07 | 20.74x |
| 2025-07-03 | 20.93x |
| 2025-07-02 | 21.03x |
| 2025-07-01 | 21.32x |
| 2025-06-30 | 20.87x |
| 2025-06-27 | 21.06x |
| 2025-06-26 | 21.20x |
| 2025-06-25 | 20.92x |
| 2025-06-24 | 20.74x |
| 2025-06-23 | 20.52x |
| 2025-06-20 | 20.50x |
| 2025-06-18 | 20.32x |
| 2025-06-17 | 20.42x |
| 2025-06-16 | 20.80x |
| 2025-06-13 | 20.49x |
| 2025-06-12 | 20.90x |
| 2025-06-11 | 20.70x |
| 2025-06-10 | 20.91x |
| 2025-06-09 | 20.83x |
| 2025-06-06 | 20.99x |
| 2025-06-05 | 20.71x |
| 2025-06-04 | 21.10x |
| 2025-06-03 | 20.89x |
| 2025-06-02 | 20.56x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra